Binding domain for p21WAF1 on the polypeptide chain of the protein kinase CK2 β-subunit

被引:17
作者
Götz, C [1 ]
Kartarius, S [1 ]
Scholtes, P [1 ]
Montenarh, M [1 ]
机构
[1] Univ Saarland, D-66421 Homburg, Germany
关键词
D O I
10.1006/bbrc.2000.2230
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinase CK2 is a ubiquitous serine/threonine kinase which is involved in many proliferation-related processes in the cell. Id is composed of two regulatory beta-subunits and two catalytic alpha-subunits. Its regulation still remains mysterious in spite of many years of intense research. One of its regulators is the cdk inhibitory molecule p21(WAF1)-a protein which is expressed in situations of genotoxic stress. p21(WAF1) binds to the beta-subunit of CK2 and inhibits the activity of CK2. Using deletion mutants of CK2 beta as well as a peptide library consisting of 15-amino-acid-long peptides derived from the polypeptide chain of CK2 beta we mapped the binding region for p21(WAF1) on the polypeptide chain of CK2 beta. We localized an amino-terminal and a carboxy-terminal binding domain. Binding of p21(WAF1) to both regions of the CK2 beta-subunit interferes with the phosphotransferase activity of the CK2 holoenzyme. (C) 2000 Academic Press.
引用
收藏
页码:882 / 885
页数:4
相关论文
共 30 条
  • [1] PROTEIN KINASES .4. PROTEIN-KINASE CK2 - AN ENZYME WITH MULTIPLE SUBSTRATES AND A PUZZLING REGULATION
    ALLENDE, JE
    ALLENDE, CC
    [J]. FASEB JOURNAL, 1995, 9 (05) : 313 - 323
  • [2] APPEL K, 1995, ONCOGENE, V11, P1971
  • [3] SER2 IS THE AUTOPHOSPHORYLATION SITE IN THE BETA-SUBUNIT FROM BICISTRONICALLY EXPRESSED HUMAN CASEIN KINASE-2 AND FROM NATIVE RAT-LIVER CASEIN KINASE-2-BETA
    BOLDYREFF, B
    JAMES, P
    STAUDENMANN, W
    ISSINGER, OG
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 218 (02): : 515 - 521
  • [4] Crystal structure of the human protein kinase CK2 regulatory subunit reveals its zinc finger-mediated dimerization
    Chantalat, L
    Leroy, D
    Filhol, O
    Nueda, A
    Benitez, MJ
    Chambaz, EM
    Cochet, C
    Dideberg, O
    [J]. EMBO JOURNAL, 1999, 18 (11) : 2930 - 2940
  • [5] Chen IT, 1996, ONCOGENE, V12, P595
  • [6] ELDEIRY WS, 1994, CANCER RES, V54, P1169
  • [7] Fotedar R, 1996, ONCOGENE, V12, P2155
  • [8] Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138
  • [9] Gotz C, 1996, ONCOGENE, V13, P391
  • [10] GOTZ C, 1998, CANC MOL BIOL, V5, P1189